'Tarlatamab's FDA approval: shaping the future of cancer therapy'.
Alamgir I, Alamgir U, Alamgir E, Qureshi AA, Siddiqui MO, Jaber MH, Motwani J.
Alamgir I, et al. Among authors: siddiqui mo.
Ann Med Surg (Lond). 2024 Sep 10;86(10):5676-5679. doi: 10.1097/MS9.0000000000002555. eCollection 2024 Oct.
Ann Med Surg (Lond). 2024.
PMID: 39359806
Free PMC article.
No abstract available.